Dissecting MECP2 function in the central nervous system

Journal of Child Neurology

Volumn 20, Issue 9, 2005, Pages 753-759

  Kishi, Noriyuki ^a   Macklis, Jeffrey D ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ARTICLE; CELL MATURATION; CENTRAL NERVOUS SYSTEM; EMBRYO DEVELOPMENT; GENE TARGETING; NERVE CELL MEMBRANE; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 27144431762     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200091001     Document Type: Article

References (56)

1. Armstrong DD: Neuropathology of Rett syndrome. Ment Retard Dev Disabil Res Rev 2002;8:72-76.
2. Glaze DG: Neurophysiology of Rett syndrome. Ment Retard Dev Disabil Res Rev 2002;8:66-71.
3. Hagberg B: Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 2002;8:61-65.
4. Kriaucionis S, Bird A: DNA methylation and Rett syndrome. Hum Mol Genet 2003;12(Suppl 2):R221-R227.
5. Shahbazian MD, Zoghbi HY: Rett syndrome and MECP2: Linking epigenetics and neuronal function. Am J Hum Genet 2002;71: 1259-1272.
6. Percy AK, Lane JB: Rett syndrome: Clinical and molecular update. Curr Opin Pediatr 2004;16:670-677.
7. Moog U, Smeets EE, van Roozendaal KE, et al: Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J Paediatr Neurol 2003;7:5-12.
8. Amir RE, Van den Veyver IB, Wan M, et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-188.
9. Lewis JD, Meehan RR, Henzel WJ, et al: Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992;69:905-914.
10. Nan X, Campoy FJ, Bird A: MECP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997;88:471-481.
11. Chen RZ, Akbarian S, Tudor M, et al: Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001;27:327-331.
12. Guy J, Hendrich B, Holmes M, et al: A mouse MECP2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001;27:322-326.
13. Shahbazian M, Young J, Yuva-Paylor L, et al: Mice with truncated MECP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002;35:243-254.
14. Moretti P, Bouwknecht JA, Teague R, et al: Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum Mol Genet 2005;14:205-220.
15. Shahbazian MD, Antalffy B, Armstrong DL, et al: Insight into Rett syndrome: MECP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 2002;11:115-124.
16. Reichwald K, Thiesen J, Wiehe T, et al: Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions. Mamm Genome 2000;11:182-190.
17. Lai EC: MicroRNAs: Runts of the genome assert themselves. Curr Biol 2003;13:R925-R936.
18. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
19. Kriaucionis S, Bird A: The major form of MECP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res 2004;32:1818-1823.
20. Mnatzakanian GN, Lohi H, Munteanu I, et al: A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 2004;36:339-341.
21. Luikenhuis S, Giacometti E, Beard CF, et al: Expression of MECP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci U S A 2004;101:6033-6038.
22. Collins AL, Levenson JM, Vilaythong AP, et al: Mild overexpression of MECP2 causes a progressive neurological disorder in mice. Hum Mol Genet 2004;13:2679-2689.
23. Cassel S, Revel MO, Kelche C, et al: Expression of the methyl-CpG-binding protein MECP2 in rat brain. An ontogenetic study. Neurobiol Dis 2004;15:206-211.
24. Cohen DR, Matarazzo V, Palmer AM, et al: Expression of MECP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neurosci 2003;22:417-429.
25. Coy JF, Sedlacek Z, Bachner D, et al: A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3″-untranslated region of the methyl-CpG-binding protein 2 gene (MECP2) suggests a regulatory role in gene expression. Hum Mol Genet 1999;8:1253-1262.
26. Jung BP, Jugloff DG, Zhang G, et al: The expression of methyl CpG binding factor MECP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J Neurobiol 2003;55:86-96.
27. Kishi N, Macklis JD: MECP2 is progressively expressed in postmigratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 2004;27:306-321.
28. Mullaney BC, Johnston MV, Blue ME: Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience 2004;123:939-949.
29. Aber KM, Nori P, MacDonald SM, et al: Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemical study of subcellular fractions. Neuroscience 2003;116:77-80.
30. Georgel PT, Horowitz-Scherer RA, Adkins N, et al: Chromatin compaction by human MECP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem 2003;278:32181-32188.
31. Stancheva I, Collins AL, Van den Veyver IB, et al: A mutant form of MECP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by Notch in Xenopus embryos. Mol Cell 2003;12:425-435.
32. Artavanis-Tsakonas S, Rand MD, Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-776.
33. Tomita K, Ishibashi M, Nakahara K, et al: Mammalian hairy and Enhancer of split homolog 1 regulates differentiation of retinal neurons and is essential for eye morphogenesis. Neuron 1996;16:723-734.
34. Swiatek PJ, Lindsell CE, del Amo FF, et al: Notch1 is essential for postimplantation development in mice. Genes Dev 1994;8:707-719.
35. Oka C, Nakano T, Wakeham A, et al: Disruption of the mouse RBP-J kappa gene results in early embryonic death. Development 1995;121:3291-3301.
36. Conlon RA, Reaume AG, Rossant J: Notch1 is required for the coordinate segmentation of somites. Development 1995;121:1533-1545.
37. Zhao X, Ueba T, Christie BR, et al: Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc Natl Acad Sci U S A 2003;100:6777-6782.
38. Chen WG, Chang Q, Lin Y, et al: Depression of BDNF transcription involves calcium-dependent phosphorylation of MECP2. Science 2003;302:885-889.
39. Horike S, Cai S, Miyano M, et al: Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005;37:31-40.
40. Martinowich K, Hattori D, Wu H, et al: DNA-methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003;302:890-893.
41. Matarazzo V, Cohen D, Palmer AM, et al: The transcriptional repressor MECP2 regulates terminal neuronal differentiation. Mol Cell Neurosci 2004;27:44-58.
42. Armstrong D, Dunn JK, Antalffy B, et al: Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 1995;54:195-201.
43. Bauman ML, Kemper TL, Arin DM: Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 1995;45:1581-1586.
44. Bauman ML, Kemper TL, Arin DM: Microscopic observations of the brain in Rett syndrome. Neuropediatrics 1995;26:105-108.
45. Gorski JA, Zeiler SR, Tamowski S, et al: Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 2003;23:6856-6865.
46. Xu B, Zang K, Ruff NL, et al: Cortical degeneration in the absence of neurotrophin signaling: Dendritic retraction and neuronal loss after removal of the receptor TrkB. Neuron 2000;26:233-245.
47. Gates MA, Tai CC, Macklis JD: Neocortical neurons lacking the protein-tyrosine kinase B receptor display abnormal differentiation and process elongation in vitro and in vivo. Neuroscience 2000;98:437-447.
48. Egaas B, Courchesne E, Saitoh O: Reduced size of corpus callosum in autism. Arch Neurol 1995;52:794-801.
49. Gotoh H, Suzuki I, Maruki K, et al: Magnetic resonance imaging and clinical findings examined in adulthood-Studies on three adults with Rett syndrome. Brain Dev 2001;23(Suppl 1):S118-S121.
50. Escayg A, MacDonald BT, Meisler MH, et al: Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000;24:343-345.
51. Wallace RH, Wang DW, Singh R, et al: Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet 1998;19:366-370.
52. Lunyak VV, Burgess R, Prefontaine GG, et al: Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 2002;298:1747-1752.
53. Planells-Cases R, Caprini M, Zhang J, et al: Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. Biophys J 2000;78:2878-2891.
54. Stuhmer T, Anderson SA, Ekker M, et al: Ectopic expression of the Dlx genes induces glutamic acid decarboxylase and Dlx expression. Development 2002;129:245-252.
55. Amir RE, Van den Veyver IV, Wan M, et al: Rett syndome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics 1999;23(2):127-128.
56. Rett A: Uber ein zerebral-atrophisches Syndrome bei Hyperammonemie. Wien Med Wochenschr 1966;116:723-726.